Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more
Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Innovative regenerative medicines in the EU: a better future in evidence?

  • Mark S. Corbett1Email author,
  • Andrew Webster2,
  • Robert Hawkins3 and
  • Nerys Woolacott1
BMC Medicine201715:49

https://doi.org/10.1186/s12916-017-0818-4

Received: 19 October 2016

Accepted: 14 February 2017

Published: 8 March 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
19 Oct 2016 Submitted Original manuscript
3 Nov 2016 Reviewed Reviewer Report - Henk Guchelaar
21 Dec 2016 Reviewed Reviewer Report - Romaldas Maciulaitis
19 Jan 2017 Author responded Author comments - Mark Corbett
Resubmission - Version 2
19 Jan 2017 Submitted Manuscript version 2
31 Jan 2017 Reviewed Reviewer Report - Henk Guchelaar
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
14 Feb 2017 Editorially accepted
8 Mar 2017 Article published 10.1186/s12916-017-0818-4

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Centre for Reviews and Dissemination, University of York
(2)
Science and Technology Studies Unit, Department of Sociology, University of York
(3)
Medical Oncology, The Christie Hospital and University of Manchester

Advertisement